| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 06/07/2011 | CA2424483C Use of bromelain for the treatment of inflammatory diseases and for adjuvant therapy during wound healing processes |
| 06/07/2011 | CA2378866C Fc fusion proteins for enhancing the immunogenicity of protein and peptide antigens |
| 06/07/2011 | CA2306216C The use of inhibitors of the renin-angiotensin system for the treatment of cachexia and wasting |
| 06/03/2011 | WO2011066506A1 2-METHYLENE-19,26-NOR-(20S)-1α-HYDROXYVITAMIN D3 |
| 06/03/2011 | WO2011066390A2 Nanoscale adjuvants and related pharmaceutical compositions and methods |
| 06/03/2011 | WO2011066184A1 Novel compounds as receptor modulators with therapeutic utility |
| 06/03/2011 | WO2011066179A1 Novel compounds as receptor modulators with therapeutic utility |
| 06/03/2011 | WO2011065923A1 Treatment and prevention of cancers associated with intracellular oncoproteins by antibody therapy or vaccination |
| 06/03/2011 | WO2011065402A1 Indole compound and pharmaceutical use thereof |
| 06/03/2011 | WO2011064753A1 Pharmaceutical compositions and therapeutic applications of a hydrocortisone derivative designated as deina |
| 06/03/2011 | WO2011064657A2 Quinazolin-4(3a)-one derivatives and methods of use thereof |
| 06/03/2011 | WO2011063660A1 Optimized flagellin protein, preparation method and use thereof |
| 06/03/2011 | WO2011042473A3 Estrogen receptor ligands |
| 06/03/2011 | WO2011041146A3 Dosage regimen of an s1p receptor modulator |
| 06/03/2011 | WO2011041145A3 Method and system for accessing patient data |
| 06/03/2011 | WO2011033225A3 Substituted 3-amino-cinnolin-4(1h)-one derivatives, preparation thereof, and therapeutic use thereof |
| 06/03/2011 | WO2011030332A3 Methods for hematopoietic precursor mobilization |
| 06/03/2011 | WO2010138193A3 Targeted synthetic nanocarriers with ph sensitive release of immunomodulatory agents |
| 06/03/2011 | WO2010138192A3 Nanocarriers possessing components with different rates of release |
| 06/03/2011 | CA2782218A1 Antibody fc mutants with ablated effector functions |
| 06/03/2011 | CA2781889A1 2-methylene-19,26-nor-(20s)-1.alpha.-hydroxyvitamin d3 |
| 06/03/2011 | CA2781660A1 Indole compound and pharmaceutical use thereof |
| 06/03/2011 | CA2781645A1 Compositions, methods and uses for expression of enterobacterium-associated peptides |
| 06/03/2011 | CA2780987A1 Novel compounds as receptor modulators with therapeutic utility |
| 06/03/2011 | CA2780908A1 Novel compounds as receptor modulators with therapeutic utility |
| 06/02/2011 | US20110130705 Therapy for vitiligo |
| 06/02/2011 | US20110130453 Aminoalkylphenyl antagonists of prostaglandin d2 receptors |
| 06/02/2011 | US20110130452 Store-operated calcium cellular assay |
| 06/02/2011 | US20110130442 Nucleic acid capable of controlling degranulation of mast cell |
| 06/02/2011 | US20110130436 Caspase inhibitors and uses thereof |
| 06/02/2011 | US20110130415 Protein kinase c inhibitors and uses thereof |
| 06/02/2011 | US20110130409 Substituted 1,2,3,4-tetrahydrocyclopenta[b]indol-3-yl)acetic acid derivatives useful in the treatment of autoimmune and inflammatory disorders |
| 06/02/2011 | US20110130403 Pyrazolo [3, 4-b] pyridine derivatives as phosphodiesterase inhibitors |
| 06/02/2011 | US20110130395 P13k isoform selective inhibitors |
| 06/02/2011 | US20110130391 Ureido substituted benzoic acid compounds and their use for nonsense suppression and the treatment of disease |
| 06/02/2011 | US20110130380 Heteroaryl Kinase Inhibitors |
| 06/02/2011 | US20110130374 Small Pyrimidine Derivatives and Methods of Use Thereof |
| 06/02/2011 | US20110130364 Pyrrolopyridine derivatives substituted with cyclic amino group |
| 06/02/2011 | US20110130353 Highly purified antiendotoxin compound |
| 06/02/2011 | US20110130349 Compounds and Methods for Treating Toll-Like Receptor 2-Related Diseases and Conditions |
| 06/02/2011 | US20110130324 Methods for systematic control of protein stability |
| 06/02/2011 | US20110129896 INHIBITORS OF GSK-3 AND CRYSTAL STRUCTURES OF GSK-3Beta PROTEIN AND PROTEIN COMPLEXES |
| 06/02/2011 | US20110129883 Inactivation of genes of the mep pathway |
| 06/02/2011 | US20110129548 Immunopotentiating Compositions Comprising Beta-1, 3/1, 6-D-Glucan and Uses Thereof |
| 06/02/2011 | US20110129525 Mucosal membrane receptor and uses thereof |
| 06/02/2011 | US20110129503 Tumor vaccination in combination with hematopoietic cell transplantation for cancer therapy |
| 06/02/2011 | US20110129500 Lawsonia intracellularis bacterium of a novel serotype, vaccine based on that bacterium, antibodies suitable for diagnosing the novel lawsonia intracellularis serotype and hybridomas for producing the said antibodies |
| 06/02/2011 | US20110129499 Dual delivery system for heterologous antigens |
| 06/02/2011 | US20110129498 Vaccine for the prevention and therapy of hcv infections |
| 06/02/2011 | US20110129497 Methods for designing and preparing vaccines comprising directed sequence polymer compositions via the directed expansion of epitopes |
| 06/02/2011 | US20110129494 Vaccine Formulations Comprising Saponin-containing Adjuvants |
| 06/02/2011 | US20110129490 Modulation of production of retroviruses by apobec4 |
| 06/02/2011 | US20110129489 Methods for generating an immune response using dna and a viral vector |
| 06/02/2011 | US20110129487 Plasmic production and expression of recombinant proteins in cells grown without antibiotics |
| 06/02/2011 | US20110129486 Methods of treating inflammatory colon diseases |
| 06/02/2011 | US20110129485 Modified Galectin-2 and Uses Thereof |
| 06/02/2011 | US20110129484 Immunotherapies employing self-assembling vaccines |
| 06/02/2011 | US20110129483 Membrane transporter NaPi2b (SCL34A1) epitope for antibody therapy, antibodies directed thereto, and target for cancer therapy |
| 06/02/2011 | US20110129479 Immunogen selection directed in immunoglobulin packages in plasma and colostrum and method of making and using same |
| 06/02/2011 | US20110129476 Mzb1, a novel b cell factor, and uses thereof |
| 06/02/2011 | US20110129468 Purified immunoglobulin fusion proteins and methods of their purification |
| 06/02/2011 | US20110129465 Mammalian Receptor Proteins; Related Reagents and Methods |
| 06/02/2011 | US20110129463 Quinazolin-4(3A)-One Derivatives and Methods of Use Thereof |
| 06/02/2011 | US20110129458 Binding molecules with multiple binding sites, compositions comprising the same and uses thereof |
| 06/02/2011 | US20110129452 PROBIOTICS TO INCREASE IgA SECRETION IN INFANTS BORN BY CAESAREAN SECTION |
| 06/02/2011 | US20110129448 Methods to mobilize progenitor/stem cells |
| 06/02/2011 | US20110129447 Methods for Cell Expansion and Uses of Cells and Conditioned Media Produced Thereby for Therapy |
| 06/02/2011 | US20110129441 Method and system to remove soluble tnfr1, tnfr2, and il2 in patients |
| 06/01/2011 | EP2327779A1 New therapeutic agent for malignant mesothelioma and immunostimulant |
| 06/01/2011 | EP2327712A2 Treatment of autoimmune conditions with copolymer 1 and related copolymers and peptides |
| 06/01/2011 | EP2327702A1 Mitotic kinesin inhibitor |
| 06/01/2011 | EP2327423A2 Human antibodies against human interleukin-22 (IL-22) |
| 06/01/2011 | EP2327418A1 Recombinant parainfluenza virus expression systems and vaccines comprising heterologous antigens derived from other viruses |
| 06/01/2011 | EP2327408A1 Tetracyclic cyclic gmp-specific phosphodiesterase inhibitors for the treatment of benign prostatic hypertrophy |
| 06/01/2011 | EP2326671A1 Lps based vaccines |
| 06/01/2011 | EP2326668A1 Anti-il-12/il-23 antibodies |
| 06/01/2011 | EP2326647A1 6-substituted 2-(benzimidazolyl)purine and purinone derivatives and 6-substituted 2-(imidazoioý4,5- c¨pyridinyl)purine and purinone derivatives for immunosuppression |
| 06/01/2011 | EP2326646A1 Purine derivatives for use in the treatment of allergic, inflammatory and infectious diseases |
| 06/01/2011 | EP2326634A1 Chromene modulators of chemokine receptor activity |
| 06/01/2011 | EP2326621A1 SUBSTITUTED 1,2,3,4- TETRAHYDROCYCLOPENTA[b]INDOL-3-YL) ACETIC ACID DERIVATIVES USEFUL IN THE TREATMENT OF AUTOIMMUNE AND INFLAMMATORY DISORDERS |
| 06/01/2011 | EP2326315A1 Treatment of an autoimmune disease using il-18 antagonists |
| 06/01/2011 | EP1073759B1 Recombinant virus expressing foreign dna encoding feline cd80, feline cd28, feline ctla-4 or feline cd86 and uses thereof |
| 06/01/2011 | CN102083986A Attenuated recombinant alphaviruses incapable of replicating in mosquitoes and uses thereof |
| 06/01/2011 | CN102083966A Method to induce and expand therapeutic alloantigen-specific human regulatory T cells in large-scale |
| 06/01/2011 | CN102083828A Heterocyclic compounds and compositions as C-KIT and PDGFR kinase inhibitors |
| 06/01/2011 | CN102083826A Inhibitors of phosphatidylinositol 3-kinase |
| 06/01/2011 | CN102083819A Novel phenylpyrazinones as kinase inhibitors |
| 06/01/2011 | CN102083800A Heteroaryl compounds and uses thereof |
| 06/01/2011 | CN102083463A Expression vector encoding alphavirus replicase and the use thereof as immunological adjuvant |
| 06/01/2011 | CN102083431A Use of cyclolignans for the treatment of a hyperactive immune system |
| 06/01/2011 | CN102080117A Inflammatory factor receptor antagonist of microbial source and preparation method thereof |
| 06/01/2011 | CN102079787A Antihuman CD52 engineering antibody, carrier, kit and application thereof |
| 06/01/2011 | CN102079785A Thymopoietin-II mutant |
| 06/01/2011 | CN102079769A Cyclopropyl pregnene compound and application thereof |
| 06/01/2011 | CN102079746A Pyrazolo-quinazoline derivatives,process for their preparation and their use as kinase inhibitors |
| 06/01/2011 | CN102079743A Dipeptidyl peptidase inhibitors |
| 06/01/2011 | CN102078621A Method and composition of regulating and controlling plasmacytoid dendritic cell I type interferon expression |
| 06/01/2011 | CN102078619A Transdermal therapeutic preparation |
| 06/01/2011 | CN102078612A Nasal in-situ gel containing mometasone furoate and H1 receptor antagonist |
| 06/01/2011 | CN102078608A Formulation of human antibodies for treating tnf-alpha associated disorders |